Onlikon: Announcement on the subsidiary\'s renewal of the “Veterinary Drug GMP Certificate” and passing the GMP compliance inspection
Onlikon: Announcement on the actual controller\'s renewal of the concerted action agreement
Onlikon: Announcement on Subsidiaries Obtaining Drug Registration Certificates
Onlikon: Announcement on the extension of the term of the first employee stock ownership plan
Onlikang: Announcement on the completion of the registration of industrial and commercial changes by the subsidiary Jiangxi Chundi Biotechnology Co., Ltd.
Onlikon: Announcement on Continued Supervision of Changes in Sponsor Entities
Onlikang: Announcement on the purchase of part of the minority shares of Jiangxi Chundi Biotechnology Co., Ltd. by its subsidiary Hunan Kerui Biopharmaceutical Co., Ltd.
Onlykang: Summary table of non-operating capital usage and other related capital transactions for the half year
Onlikon: 2024 Semi-Annual Financial Report
Zhejiang Anglikang Pharmaceutical: Announcement on Pharmaceutical Registration Approval for Collaborative Product Lanthanum Carbonate Chewable Tablets
Zhejiang Anglikang Pharmaceutical: Announcement Regarding Changes to the Business Scope and Revision of the Articles of Association and Completion of Industrial and Commercial Registration Changes.
Zhejiang Anglikang Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Zhejiang Anglikang Pharmaceutical: Legal Opinion of Zhejiang Tianze Law Firm on the 2023 Annual General Meeting of Shareholders of Zhejiang Anglikang Pharmaceutical Co., Ltd.
Zhejiang Anglikang Pharmaceutical: Announcement on the completion of the election of the Board of Directors and the Board of Supervisors and the appointment of senior managers, heads of internal audit and representatives of securities affairs
Zhejiang Anglikang Pharmaceutical: Announcement on the election of employee representative supervisors of the fourth board of supervisors
Zhejiang Anglikang Pharmaceutical: Prompt Announcement on Convening the 2023 Annual General Meeting of Shareholders
Zhejiang Anglikang Pharmaceutical: Announcement on the subsidiary passing the high-tech enterprise certification
Onlikon: Announcement on preparation for impairment of assets accrued for 2023
Onlikon: Amendments to the Articles of Association
Onlikon: Accounting Services Selection and Employment System (April 2024)
No Data
No Data